baber/WOPTO huggingface dataset:
Patent EP-1348771-B1 (EP)
Inventor: OKADA HIROYUKI
IPC: C22C38/04
Filed: 2001-12-07
Granted: 2008-11-26
Abstract: Disclosed are a high strength hot rolled steel plate, preventing a deterioration in bore expandability and ductility involved in an increase in strength to not less than 690 N/mm<2> and, despite high strength, providing a high level of bore expandability and a high level of ductility, and a producing process thereof. The steel plate according to the first aspect is a steel plate, comprising a steel comprising, by mass, C:0.01-0.15%; Si:0.30-2.00%; Mn:0.50-3.00%; P≤0.03%; S≤0.005%; Ti:0.01-0.50% and/or Ni:0.01-0.05%; and the balance consisting of Fe and unavoidable impurities, not less than 80% of all grains being accounted for by grains having a ratio (ds/dl) of minor axis (ds) to major axis (dl) of not less than 0.1, the steel plate having a steel structure comprising not less than 80% of ferrite and the balance consisting of bainite, the steel plate having a strength of not less than 690 N/mm<2>. The steel plate according to the second aspect is a steel plate wherein, in the steel plate having the above composition, the steel plate has a ferrite-bainite duplex steel structure, in which the proportion of ferrite having a grain diameter of not less than 2  mu m is not less than 80%, and has a strength of not less than 690 N/mm<2>. The steel plate according to the third aspect is a steel plate comprising a steel wherein, in the steel having the above composition, the contents of C, Si, Mn, Ti and Nb satisfying a requirement represented by formula: 115 ≤ (917 - 480 ÄC%Ü + 100 ÄSi%Ü - 100 ÄMn%Ü) - (790 x (ÄTi%Ü + ÄNb%Ü/2)<0.05>) ≤ 235, and the steel plate has a steel structure comprising not less than 80% of ferrite and the balance consisting of bainite and has a strength of not less than 770 N/mm<2>. <IMAGE>
Patent EP-1243874-B1 (EP)
Inventor: BRAND HOLGER
IPC: F24S10/75
Filed: 2002-03-07
Granted: 2006-05-31
Abstract: The solar collector has a profiled frame (2) with glass top (3) and absorber (5). The absorber is fastened pivoted to the collector via an absorber holder (7) with spring element (11), esp. to its lower base plate (4). The holder is a wire bracket suspended with one of its ends (pivot axis 9) in retainers (8) in the plate. The bracket is of stainless spring steel.
Patent EP-1300951-B1 (EP)
Inventor: GUDE MICHAEL DR
IPC: H03M3/02
Filed: 2002-09-29
Granted: 2007-09-26
Abstract: The stabilized power supply of the input and output buffers (5,6) separated from a semiconductor chip having digital circuitry, are located in front of the D-input of a flip-flop (4) and behind the output of the flip-flop in the feedback path respectively such that decoupling formed between the semiconductor chip and the analog front end of the delta sigma analog to digital converter.
Patent EP-1286091-B1 (EP)
Inventor: BROOKES GEORGE
IPC: F16K17/38
Filed: 2002-06-07
Granted: 2005-03-23
Abstract: A heat activated isolation valve comprises a housing (1) which defines a passageway, a valve member located within the passageway, a spindle (4) extending through an opening in the housing (1) from the valve member and being rotatable relative to the housing about a pre-determined axis, and at least one seal arranged between the valve member and the housing, the valve member defining a bore therethrough and being rotatable by the spindle (4) between a valve open position in which the bore communicates with the passageway on opposite sides of the valve member and a valve closed position in which the bore is isolated from the passageway on at least one side of the valve member, wherein a spring biased mechanism is provided which is arranged to move the valve member to the closed position if the temperature exceeds a pre-determined limit. <IMAGE>
Patent EP-1266631-B1 (EP)
Inventor: JONES DONALD K
IPC: A61B17/12
Filed: 2002-06-13
Granted: 2007-05-09
Abstract: A coil for occluding the vasculature of a patient. The coil has a textured surface which provides improved platelet adhesion compared to a non-textured surface, to promote clotting. The coil comprises a platinum-tungsten alloy wire and the texturing is performed by abrasion or sandblasting to provide substantially uniform roughness comprising pockets having diameters of about 0.125  mu m to about 50 mu m and depths of about 0.25  mu m to about 20  mu m.
Patent EP-1281414-B1 (EP)
Inventor: TURNBULL CHRISTOPHER STRATTON
IPC: A61M16/04
Filed: 2002-06-26
Granted: 2004-09-01
Abstract: A tracheostomy tube introducer 2 has a straight handle 20 of a rigid plastics material moulded onto a curved midsection 21. The midsection comprises an outer shaft 29 of a polyurethane and an inner rigid metal tube 28. The outer shaft 29 continues forwardly beyond the end of the metal tube 28 to provide a flexible, tapering patient end tip 22. When inserted in a tracheostomy tube 1, the handle 20 protrudes from the machine end 13, the midsection 21 retains the tube in the desired curvature for insertion in the patient, and the patient end provides a flexible tip 22 that protrudes by about three times the external diameter of the tube. <IMAGE>
Patent EP-1293962-B1 (EP)
Inventor: NGUYEN PATRICK
IPC: G10L15/28
Filed: 2002-08-16
Granted: 2007-01-03
Abstract: An e-mail message process is provided for use with a personal digital assistant which allows for the use of input speech messaging which is converted to text using a focused language model which is downloaded by a cellular phone connection to an Internet server which provides the focused language model based upon a topic for the intended e-mail message. The text that is generated from the input speech method can be summarized by the e-mail message processor and can be edited by the user. The generated e-mail message can then be transmitted again via cellular connection to an Internet e-mail server for transmitting the e-mail message to a recipient. <IMAGE>
Patent EP-1354189-B1 (EP)
Inventor: WOLF ANDREAS
IPC: G01N21/3563
Filed: 2002-01-22
Granted: 2007-04-25
Abstract: The present invention relates to a method for determining the condition of a biological fluid by recording the IR spectrum of a sample of the biological fluid. To this end, the biological fluid can be examined in its native form. The method of the invention is usable, for example, for detecting pathological conditions in organisms.
Patent EP-1374540-B1 (EP)
Inventor: MAXWELL RICHARD
IPC: H04M3/30
Filed: 2002-03-12
Granted: 2010-02-24
Abstract: A method of operating a fault management system for an access network which forms part of a communications network. In the access network, terminating lines in the form of pairs of wires extend from a local switch (10) through a series of nodes to terminal equipment provided for user of the network. Each night, system performs a series of tests on each of the lines. The results of the tests then analysed with respect of a set of parameters to identify characteristics that would indicate that a fault is likely to occur on the associated circuit within a predetermined period e.g. 1 year. Further analysis is then be carried out to establish a score which ranks each node in the network in terms of the urgency of any preventive maintenance required. <IMAGE>
Patent EP-1368200-B1 (EP)
Inventor: KHAN NAZIR
IPC: C09D7/61
Filed: 2002-03-18
Granted: 2006-12-20
Abstract: A method for providing an image on a substrate, which comprises applying, to a relatively small area of the substrate, a formulation comprising a pigment and one or more other components that form an image on irradiation with laser light, and irradiating the area, wherein the image has greater constrast with respect to the pigment than with respect to the substrate.
Patent EP-1370693-B1 (EP)
Inventor: LI JING
IPC: C12Q1/6886
Filed: 2002-02-12
Granted: 2008-06-04
Abstract: There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the WIP1 gene, which are amplified breast, and/or lung, and/or colon, and/or ovarian, and/or prostate cancer genes. The WIP1 gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.
Patent EP-1403640-B1 (EP)
Inventor: NOKIHARA KIYOSHI
IPC: G01N33/58
Filed: 2002-05-07
Granted: 2007-12-05
Abstract: A peptide-immobilized baseboard for assaying a target protein comprises a chemically synthesized peptide, which is capable of binding to a definite stereostructure or the target protein and can bind to the target protein, immobilized on a baseboard. Independent claims are also included for (1) Assaying a target protein by contacting a target protein with the peptide-immobilized baseboard, and measuring the change in signals due to binding between such peptide with the target protein; (2) Assaying a protein in a test sample by using the peptide-immobilized baseboard that contains a plurality of the same or different chemically synthesized peptides of the already-specified properties for reacting and binding with target protein(s) in the sample before measuring the changes in signals due to their binding activity, evaluating and conversion of the visible values corresponding to the various peptides for output of the data; and (3) Identifying or specifying a protein in the test sample by performing the assay, accumulating data before transferring into a database for processing with comparison with those already known to identify or specify the protein.
Patent EP-1392917-B1 (EP)
Inventor: GUSTAFSON ERIC J
IPC: D21F3/06
Filed: 2002-03-04
Granted: 2006-05-10
Abstract: A shoe press includes: a first member; a second member; a substantially cylindrical belt; and a processing unit. The first member has a convex pressing surface. The second member includes a shoe with a concave pressing surface substantially complimentary to the convex pressing surface. The second member further includes a pair of substantially circular head plates rotatably mounted on axially opposed ends thereof. The belt is fixed to, extends between, and is rotatable with the head plates such that a portion of the belt passes between the convex pressing surface and the concave pressing surface. The belt includes embedded therein a communications cable having a plurality of sensors configured to generate signals responsive to an operating parameter of the shoe press. The processing unit is in communication with the communications cable and processes signals generated by the sensors. Thus, signals generated by the sensors and processed by the processing unit represent conditions (particularly pressure, nip width, temperature, strain and stress) within the nip of the shoe press that can be displayed and understood by an operator.
Patent EP-1383696-B1 (EP)
Inventor: KRANNICH EDMUND
IPC: B05C3/10
Filed: 2002-04-12
Granted: 2005-08-10
Abstract: The invention relates to a conveyor device which is used to transport work-pieces, especially the work-pieces of motor vehicle bodies, through a processing area for surface treatment of said work-pieces, comprising a conveyor which brings the work-pieces which are respectively maintained by a holder into the processing area; transports them through said area and removes them therefrom. The inventive conveyor device requires less maintenance in comparison with known conveyor devices. The holders respectively comprise a base part which moves in a translatory movement along a conveyor device and a rotating part on which the work-piece is arranged and which is held in such a way that it is rotatable on the base part. The conveyor comprises at least one drive device enabling at least one directly driven respective holder to be driven directly in a movement along the conveyor device. The movement of the directly driven holder is transferred to an indirectly driven holder as a result of the contact between the directly driven holder and said at least one indirectly driven holder.
Patent EP-1386012-B1 (EP)
Inventor: BOCKEL-MACAL SAVINE
IPC: C21D1/34
Filed: 2002-04-19
Granted: 2005-03-16
Abstract: The method and apparatus for enhancing the metallurgical quality of products treated in a furnace with several zones, wherein the temperature and the atmospheric conditions can be controlled. The applies to any type of product treated in a furnace, such as billets, blooms, slugs or slabs. Alternatively, this may be used by iron and steel manufacturers in the production line for sheets, plates, tubes, etc.
Patent EP-1483836-B1 (EP)
Inventor: FORRESTER TIMOTHY
IPC: H04B1/44
Filed: 2002-07-01
Granted: 2008-09-17
Abstract: A system and a method for providing a global positioning system (GPS) enabled antenna system are provided. The GPS enabled antenna may be used, for example, on a wireless communications device such as a wireless handset. The wireless communications device may include a switching module that can selectively switch communications signals between the antenna and one of a plurality of communications band circuits. A respective impedance matching circuit may be provided between the switching module and particular communications band circuitry to match or to tune the antenna to the particular communications band circuitry.
Patent EP-1389121-B1 (EP)
Inventor: SHI RIYI
IPC: A61K31/00
Filed: 2002-04-24
Granted: 2012-02-22
Abstract: To achieve, an in vivo repair of injured mammalian nerve tissue, an effective amount of a biomembrane fusion agent is administered to the injured nerve tissue. The application of the biomembrane fusion agent may be performed by directly contacting the agent with the nerve tissue at the site of the injury. Alternatively, the biomembrane fusion agent is delivered to the site of the injury through the blood supply after administration of the biomembrane fusion agent to the patient. The administration is preferably by parenteral administration including including intravascular, intramuscular, subcutaneous, or intraperitoneal injection of an effective quantity of the biomembrane fusion agent so that an effective amount is delivered to the site of the nerve tissue injury.
Patent EP-1413161-B1 (EP)
Inventor: TRINH PHU
IPC: H04W8/18
Filed: 2002-07-16
Granted: 2008-11-26
Abstract: Système de télécommunication, tel qu'un système de télécommunication mobile, comprenant une pluralité de réseaux, tels que des réseaux de propriété et commande en commun. Des cartes à puce permettent aux terminaux du système de communiquer. Si les réseaux sont des réseaux  GSM ou UMTS, les cartes à puce peuvent être des cartes SIM. Un centre (10) de gestion de cartes SIM met en oeuvre le processus normalement mis en oeuvre par un exploitant de réseau pour enregistrer une des cartes SIM avec son réseau (en tant que son réseau  « de rattachement »), au moyen d'informations fournies par le fournisseur de la carte SIM. Un terminal (p.ex. un téléphone portable) peut donc être utilisé dans ce réseau de rattachement en association avec la carte SIM. De plus, il peut être utilisé dans d'autres réseaux (appartenant ou non au système) selon les procédures d' « itinérance » normales. Cependant, si le client, envisage une visite prolongée (mais pas un déménagement permanent) à un autre des réseaux du système, le centre (10) de gestion de la carte SIM peut enregistrer une nouvelle fois la carte à puce avec ce réseau en tant que son nouveau réseau de rattachement. Lorsque le terminal avec lequel est associé la carte à puce est opérationnel dans le nouveau réseau de rattachement, il fonctionne comme un terminal quelconque, au moyen d'une carte à puce enregistrée avec ce réseau, comme son réseau de rattachement. Dans ce réseau, le terminal génère ses propres données d'authentification et ne doit pas forcément retourner au réseau de rattachement d'origine pour cela. La carte à puce peut éventuellement contenir un MSISDN additionnel approprié pour le nouveau réseau de rattachement. Si le client est un client signataire d'un contrat, la facturation est imputée au réseau de rattachement d'origine, et donc au client. Si le client est un client ayant payé préalablement, le payement est réalisé par l'achat de crédits appropriés au nouveau réseau de rattachement. Des informations confidentielles se rapportant à tous les réseaux sont stockées d'avance dans chaque carte SIM lors de l'établissement. Les enregistrements spécifiques à un réseau particulier doivent simplement être activés lorsque la carte SIM est enregistrée avec ce réseau.
Patent EP-1406843-B1 (EP)
Inventor: SCHREMMER ISTVAN
IPC: C02F1/461
Filed: 2002-07-16
Granted: 2005-03-23
Abstract: The object of the present invention is a method and an apparatus for underwater decomposition of organic content of aqueous waste solutions, involving the measurement and, if necessary, adjustment of the pH and electric conductivity of the solution, maintaining optimum pH and/or electric conductivity during the process, and further involving the partial or total decomposition of organic materials contained by the solution. The apparatus comprises a feed tank, at least one decomposition loop, and a storage tank. The method according to the invention is characterised by submerging electrodes in the solution, producing and maintaining an electric arc between the electrodes and the electrically conductive the solution, where the arc is produced by an electric current of at least 0,5 A/cm2 current density at a voltage of at least 70 V and by a symmetrical alternating current having preferably a frequency of at least 10Hz; and by decomposing the organic content of the solution into water, carbon dioxide, and nitrogen.
Patent EP-1414455-B1 (EP)
Inventor: COCHRAN JOHN E
IPC: A61P9/00
Filed: 2002-06-11
Granted: 2008-11-26
Abstract: The present invention relates to inhibitors (Ia-Ib) of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders. All substituents are as in claim 1.
Patent EP-1407560-B1 (EP)
Title: Diffusion audio/vidéo numérique sur des systèmes cellulaires
Inventor: COOPER JEFFREY ALLEN
IPC: H04H20/00
Filed: 2002-07-12
Granted: 2007-03-07
Abstract: L'invention concerne un procédé permettant de fournir des informations à plusieurs dispositifs de communications mobiles sans fil. Le procédé consiste à attribuer au moins un canal (3061) d'une pluralité de canaux (306) de données à étalement de spectre en tant que canal de diffusion. La fréquence et la phase d'un signal porteur et d'une horloge (206) de débit des éléments desdits canaux sont synchronisés pour chacun d'une pluralité d'émetteurs cellulaires (204) d'une pluralité correspondante de stations de base (134). Les informations sont alors diffusées sur au moins un canal spécialisé à partir de chaque station de base.
Patent EP-1435874-B1 (EP)
Inventor: JOHNSON RANDOLPH MELLUS
IPC: A61F2/02
Filed: 2002-08-29
Granted: 2008-08-13
Abstract: The invention features devices and methods for treatment of pain. The drug delivery device is a drug delivery system adapted for whole implantation in a subject and to provide pain relief by delivery of fentanyl or a fentanyl congener (e.g., sufentanil) over a protracted period of time (e.g., at least 3 days or more than 3 days). The device comprises a housing defining a reservoir that contains a drug formulation, a pump operatively connected to the housing so as to facilitate movement of drug out of the reservoir and out of the device, and a thermal expansion element which defines a flow pathway comprising a thermal expansion channel to accommodate thermal expansion of formulation in the reservoir. The device can further comprise a valve positioned within the flow pathway so as to prevent movement of drug out of the reservoir prior to use.
Patent EP-1415390-B1 (EP)
Inventor: BERROTH HANSJOERG
IPC: H02P6/28
Filed: 2002-07-20
Granted: 2005-03-23
Abstract: A method is disclosed for controlling the commutation in an electronically commutated motor ( 20 ) which comprises a stator having at least one phase ( 24, 26 ), and a permanent-magnet rotor ( 22 ), and with which a current limiter ( 36, 58 ) and a controller ( 18 ) for regulating a motor variable are associated. The current limiter ( 36, 58 ) serves to limit the current (I) in the at least one phase ( 24, 26 ) to a setpoint value. The regulation by means of the controller ( 18 ) is accomplished by modifying the distance in time (W) between switching on (t 1 ) and switching off (t 2 ) of the current (i 1 , i 2 ) in the at least one phase. In this method, the setpoint value to which the current limiter limits the current (i 1 , i 2 ) in the relevant phase is modifiable. It is modified substantially as a function of a ratio of two times (W/T), namely as a function of the ratio of the distance in time (W) between switching on (t 1 ) and switching off (t 2 ) of the current (i 1 , i 2 ) in the relevant phase ( 24, 26 ) to the time period (T) required by the rotor, at the instantaneous rotation speed, to rotate through a specified rotation angle. A decrease in noise at low rotation speeds is thereby made possible.
Patent EP-1412368-B1 (EP)
Inventor: GAO FENG
IPC: C07H7/033
Filed: 2002-07-24
Granted: 2007-08-29
Abstract: Glucoside and glucuronide derivatives of hydromorphone, dihydromorphine, and dihydroisomorphine and pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising a glucoside or glucuronide derivative of hydromorphone, dihydromorphine, or dihydroisomorphine or a pharmaceutically acceptable salt thereof, and methods for treating or preventing pain in a patient comprising administering to a patient in need thereof a glucoside or glucuronide derivative of hydromorphone, dihydromorphine, or dihydroisomorphine or a pharmaceutically acceptable salt thereof are disclosed.
Patent EP-1425264-B1 (EP)
Inventor: JAEHNE GERHARD
IPC: C07C317/20
Filed: 2002-08-17
Granted: 2008-10-29
Abstract: The present invention is directed to C2-disubstituted indan-1-ol systems of the Formula I, physiologically acceptable salts and physiologically functional derivatives thereof, and pharmaceutical compositions comprising such compounds, salts, and derivatives, which are useful for reducing weight, for the prophylaxis or treatment of obesity, and for the prophylaxis or treatment of type II diabetes in mammals. The invention is directed also to methods for reducing weight and such treatments and prophylaxis. The invention is directed also to processes for the preparation of such compounds.